| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |